HIGHLIGHTS
- who: Minke H. T. Hartman from the (N =, ) or placebo (N =, ) in the University Medical , RB Groningen, The Netherlands have published the article: Two-year follow-up of 4 months metformin treatment vs. placebo in ST-elevation myocardial infarction: data from the GIPS-III RCT, in the Journal: (JOURNAL)
- what: The authors report the long-term effects of 4 months of metformin treatment in STEMI patients without DM on predefined secondary endpoints, including major adverse cardiac events (MACE). The authors now provide 2-year follow-up data and evaluated predefined secondary endpoints including MACE.
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.